FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

11 results

akynzeo
(Netupitant and Palonosetron)
Helsinn Therapeutics (U.S.), Inc.
Usage: AKYNZEO is indicated for the prevention of acute and delayed nausea and vomiting in adults undergoing initial and repeat courses of highly emetogenic cancer chemotherapy, used in combination with dexamethasone. It consists of palonosetron and netupitant (or fosnetupitant in injectable form).
aprepitant
(Aprepitant)
Glenmark Pharmaceuticals Inc., USA
Usage: Aprepitant is indicated for preventing chemotherapy-induced nausea and vomiting (CINV) in patients aged 12 and older undergoing highly or moderately emetogenic chemotherapy, and for preventing postoperative nausea and vomiting (PONV) in adults. It is not intended for treating established nausea and vomiting.
cinvanti
(aprepitant)
Heron Therapeutics, Inc.
Usage: CINVANTI is indicated for the prevention of acute and delayed nausea and vomiting in adults undergoing highly and moderately emetogenic cancer chemotherapy, used in combination with other antiemetics and in specific dosing regimens. It is not studied for treating established nausea and vomiting.
fosaprepitant
(FOSAPREPITANT DIMEGLUMINE)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Usage: Fosaprepitant for injection is indicated for preventing acute and delayed nausea and vomiting in adults and pediatric patients (6 months and older) undergoing highly or moderately emetogenic cancer chemotherapy. It is not studied for treating established nausea and vomiting.
ondansetron
(Ondansetron)
ACTAVIS PHARMA, INC.
Usage: Ondansetron tablets are indicated for preventing nausea and vomiting from highly and moderately emetogenic cancer chemotherapy, radiotherapy (including total body irradiation and abdominal treatments), and postoperative settings.
ondansetron
(Ondansetron)
Natco Pharma USA LLC
Usage: Ondansetron tablets are indicated for preventing nausea and vomiting from highly and moderately emetogenic cancer chemotherapy, specific radiation treatments, and postoperative nausea or vomiting.
ondansetron hydrochloride
(Ondansetron Hydrochloride)
Chartwell RX, LLC.
Usage: Ondansetron oral solution is indicated for preventing nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy, specific radiotherapy approaches, and postoperative periods.
palonosetron
(Palonosetron)
NorthStar Rx LLC
Usage: Palonosetron hydrochloride injection is indicated for preventing acute and delayed nausea and vomiting related to moderately and highly emetogenic cancer chemotherapy in adults and pediatric patients. It also prevents postoperative nausea and vomiting for up to 24 hours after surgery, but routine prophylaxis is not recommended when the risk is low.
palonosetron hydrochloride
(Palonosetron Hydrochloride)
Eugia US LLC
Usage: Palonosetron hydrochloride injection is indicated for preventing acute and delayed nausea and vomiting in adults undergoing moderately and highly emetogenic chemotherapy, as well as for preventing postoperative nausea and vomiting. It is also indicated for pediatric patients aged 1 month to under 17 years for chemotherapy-related nausea.
syndros
(Dronabinol)
Benuvia Operations, LLC
Usage: SYNDROS is indicated for the treatment of anorexia associated with weight loss in AIDS patients and for nausea and vomiting due to cancer chemotherapy in patients unresponsive to conventional antiemetics.

Medications for Chemotherapyinduced Nausea And Vomiting

akynzeo

aprepitant

cinvanti

fosaprepitant

ondansetron

ondansetron

ondansetron hydrochloride

palonosetron

palonosetron hydrochloride

syndros